401. Characterization of Carbapenemase-Producing Klebsiella pneumoniae in Clinical Center University of Sarajevo, Bosnia and Herzegovina.
- Author
-
Granov D, Dedeić-Ljubović A, and Salimović-Bešić I
- Subjects
- Academic Medical Centers, Anti-Bacterial Agents pharmacology, Bacterial Proteins metabolism, Bosnia and Herzegovina epidemiology, Carbapenems pharmacology, Cross Infection diagnosis, Cross Infection drug therapy, Cross Infection microbiology, Gene Expression, Genotype, Humans, Klebsiella Infections diagnosis, Klebsiella Infections drug therapy, Klebsiella Infections microbiology, Klebsiella pneumoniae classification, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae isolation & purification, Microbial Sensitivity Tests, Molecular Epidemiology, Multilocus Sequence Typing, Phylogeny, Plasmids chemistry, beta-Lactamases metabolism, Bacterial Proteins genetics, Cross Infection epidemiology, Disease Outbreaks, Klebsiella Infections epidemiology, Klebsiella pneumoniae genetics, Plasmids metabolism, beta-Lactam Resistance genetics, beta-Lactamases genetics
- Abstract
Klebsiella pneumoniae is the second most prevalent gram-negative rod that causes nosocomial infections in hospitalized or otherwise immunocompromised patients. It can develop multiple drug resistance that results in limited treatment options and increased use of carbapenems. Various mechanisms are related to the development of carbapenem resistance in K. pneumoniae . The aim of this study was to perform phenotypic and molecular characterization of clinical isolates of carbapenemase-producing K. pneumoniae from two outbreaks recorded in 2017 and 2018 in Clinical Center University of Sarajevo, Bosnia and Herzegovina. Identification of K. pneumoniae isolates was carried out on the basis of morphological, cultural, and biochemical characteristics. Interpretation of antimicrobial resistance was performed according to EUCAST breakpoints. There were four different resistotypes of carbapenemase-producing K. pneumoniae in this study and all were confirmed positive for bla
OXA-48 carbapenemase. Rep-PCR fingerprinting of these strains showed the presence of the two different genetic patterns with no similarity between them. The monitoring, surveillance, and molecular typing are essential to control the emergence of multidrug-resistant strains in nosocomial settings, and to reduce the frequency of outbreak occurrence.- Published
- 2020
- Full Text
- View/download PDF